Bispectral index and serum drug levels during TCI of remifentanil and propofol for cholecystectomy
S.C. Hųymork, B. Grimsmo,J. Ręder. Department. of Anaesthesia, Ullevaal
University Hospital, N‑0407, Oslo
Target control
infusion (TCI) has been used to more accurately control intravenous drug
infusions for general anaesthesia, whereas bispectral index (BIS) has been
introduced as a new way of monitoring
the level of anaesthesia in the individual patient. We wanted to study the
accuracy of TCI systems for propofol and remifentanil, the inter-individual
variation of measured serum drug levels and whether these values were
correlated with BIS.
Methods
After Ethical
Committee approval and informed consent, 20 adult outpatients, normal weight,
age 20-65 years, due for laparoscopic cholecystectomy were enrolled in an open
study. The patients received no medication except for TCI of propofol
(Diprifusor©, 5 µg/ml during induction, 3 µg/ml thereafter) and remifentanil
7.5 ng/ml during the whole procedure. Endotracheal intubation and controlled
ventilation was facilitated with rocuronium 0.6 mg/kg. By the end of the
procedure, the infusions were stopped simultaneously as the patients received
fentanyl 0.01 mg/kg. BIS values were monitored continuously (Aspect© 1050)
during the procedure. An arterial line was established for repeated
bloodsamples taken for analyses of serum propofol and remifentanil.
Results
The measured
serum levels of remifentanil were generally lower than estimated from the TCI
system, whereas the propofol values were generally higher (table 1). For both
drugs there were large interindividual variations. Those with a high level of
one drug tended to have a high level of the other drug as well, initially. In
the individual patient, the level of remifentanil was stable throughout the
procedure (p<0.005), for propofol no similar correlation was found. There
were no correlations between measured serum drug levels and BIS values. During
start of surgery high levels of remifentanil was correlated with low values of
systolic blood pressure (p<0.01).The patients opened their eyes at 16±4.5
min after stop of the infusions.
Table 1: Estimated (=target) and measured serum drug levels (mean ± SD)
|
|
Est.
remifent. |
Measured
remifent |
Est.
propofol (µg/ml) |
Measured
propofol |
|
Before
intubation |
7,50
± 0,00 |
5,68
± 2,43 |
4,99
± 0,05 |
7,69
± 1,59 |
|
Start
of surgery |
7,50±0,00 |
5,94±2,07 |
3,07±0,13 |
3,79±1,09 |
|
Stable
surgery |
7,50±0,00 |
6,60±2,33 |
3,00±0,00 |
4,62±0,96 |
|
End
of surgery 7, |
7,17±0,94 |
6,11±1,97 |
3,00±0,00 |
4,43±1,05 |
|
Eyes opening |
1,00±0,25 |
0,86±0,33 |
1,16±0,17 |
1,26±0,30 |
Discussion
Present TCI
systems for propofol and remifentanil result in large interindividual
variations in serum drug levels during laparoscopic cholecystectomy, and mean
values are different from the estimated target. Within the serum levels
measured during this surgical procedure,
BIS registration was not able to pick out patients with highly deviating
serum levels from the others. This may indicate that during cholecystectomy, BIS
is not sensitive enough to detect differences in serum drug levels within those
encountered in this study. This may be different if lower serum drug targets
and a lighter level of anaesthesia are studied.